Molecular pharmacology of the human prostaglandin D 2 receptor, CRTH2

British Journal of Pharmacology

Volumn 137, Issue 8, 2002, Pages 1163-1172

  Sawyer, Nicole ^a   Cauchon, Elizabeth ^a   Chateauneuf, Anne ^a   Cruz, Rani P G ^a   Nicholson, Donald W ^a   Metters, Kathleen M ^a   O'Neill, Gary P ^a   Gervais, Francois G ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Binding assay; CRTH2; DP; Eosinophils; Intracellular signalling; Pharmacology; Prostaglandin D 2; Prostanoid receptor; Recombinant; Tissue distribution

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN D2; 15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 15 METHYLPROSTAGLANDIN D2; CYCLIC AMP; DELTA12 PROSTAGLANDIN J2; GUANINE NUCLEOTIDE BINDING PROTEIN; ILOPROST; MESSENGER RNA; PERTUSSIS TOXIN; PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR CRTH2; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN J2; PROSTAGLANDIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; EOSINOPHIL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIGAND BINDING; MEMBRANE BINDING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

BINDING, COMPETITIVE; CELL LINE; GENE EXPRESSION REGULATION; HL-60 CELLS; HUMANS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFECTION;

EID: 0036944934     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704973     Document Type: Article

References (26)

1. Abramovitz, M., Adam, M., Bole, Y., Carriere, M., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N.M., Belley, M., Gallant, M., Dufresne, C., Gareau, Y., Ruel, R., Juteau, H., Labelle, M., Ouimet, N. & Metters, K.M. (2000). The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta, 1483, 285-293.
2. Anthony, A., Dhillon, A.P., Nygard, G., Hudson, M., Piasecki, C., Strong, P., Trevethick, M.A., Clayton, N.M., Jordan, C.C., Pounder, R.E. & Wakefield, A.J. (1993). Early histological features of small intestinal injury induced by indomethacin. Aliment. Pharmacol. Ther., 7, 29.
3. Boie, Y., Sawyer, N., Slipetz, D.M., Metters, K.M. & Abramovitz, M. (1995). Molecular cloning and characterization of the human prostanoid DP receptor. J. Biol. Chem., 270, 18910-18916.
4. Coleman, R.A., Smith, W.L. & Narumiya, S. (1994). International Union of Pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev., 46, 205-229.
5. Gervais, F.G., Cruz, R.P., Chateauneuf, A., Gale, S., Sawyer, N., Nantel, F., Metters, K.M. & O'Neill, G.P. (2001). Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J. Allergy Clin. Immunol., 108, 982-988.
6. Harris, S.G., Smith, R.S. & Phipps, R.P. (2002). 15-Deoxy-Delta(12,14)(12,14)-PGJ(2) induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J. Immunol., 168, 1372-1379.
7. Hirai, H., Tanaka, K., Takano, S., Ichimasa, M., Nakamura, M. & Nagata, K. (2002). Cutting edge: Agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J. Immunol., 168, 981-985.
8. Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K.M.N., Takano, S. & Nagata, K. (2001). Prostaglandin D2 selectively induces chemotaxis in T Helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med., 193, 255-261.
9. Matsumura, H., Nakajima, T., Osaka, T., Satoh, S., Kawase, K., Kubo, E., Kantha, S.S., Kasahara, K. & Hayaishi, O. (1994). Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc. Natl. Acad. Sci. U.S.A., 91, 11998-12002.
10. Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., Eguchi, N., Urade, Y., Yoshida, N., Kimura, K., Mizoguchi, A., Honda, Y., Nagai, H. & Narumiya, S. (2000). Prostaglandin D2 as a mediator of allergic asthma. Science, 287, 2013-2017.
11. Monneret, G., Gravel, S., Diamond, M., Rokach, J. & Powell, W.S. (2001). Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood, 98, 1942-1948.
12. Nagata, K., Tanaka, K., Ogawa, K., Kemmotsu, K., Imai, T., Yoshie, O., Abe, H., Tada, K., Nakamura, M., Sugamura, K. & Takano, S. (1999). Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol., 162, 1278-1286.
13. Narumiya, S., Sugimoto, Y. & Ushikubi, F. (1999). Prostanoid receptors: Structures, properties, and functions. Physiol. Rev., 79, 1193-1226.
14. Offermanns, S. & Simon, M.I. (1995). G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem., 270, 15175-15180.
15. Paul, C.C., Mahrer, S., Tolbert, M., Elbert, B.L., Wong, I., Ackerman, S.J. & Baumann, M.A. (1995). Changing the differentiation program of hematopoietic cells: Retinoic acid-induced shift of eosinophil-committed cells to neutrophils. Blood, 86, 3737-3744.
16. Rangachari, P.K., Betti, P.A., Prior, E.T. & Roberts, L.J. (1995). Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: An argument for a different DP receptor? J. Pharmacol. Exp. Ther., 275, 611-617.
17. Schror, K. (1978). Prostaglandin D2 (PGD2) a potent coronary vasoconstrictor agent in the guinea pig isolated heart. Naunyn Schmiedebergs Arch. Pharmacol., 302, 61-62.
18. Scoggan, K.A., Nicholson, D.W. & Ford-Hutchinson, A.W. (1996). Regulation of leukotriene-biosynthetic enzymes during differentiation of myelocytic HL-60 cells to eosinophilic or neutrophilic cells. Eur. J. Biochem., 239, 572-578.
19. Shen, T.Y. & Winter, C.A. (1977). Chemical and biological studies on indomethacin, sulindac and their analogs. In Advances in Drug Research. Simons, A.B., ed. p.89. New York: Academic.
20. Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M. & Uchida, K. (2002). 15-Deoxy-delta12,14-prostaglandin J2: A prostaglandin D2 metabolite generated during inflammatory processes. J. Biol. Chem., 10, 10.
21. Smrcka, A.V. & Sternweis, P.C. (1993). Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits. J. Biol. Chem., 268, 9667-9674.
22. Straus, D.S. & Glass, C.K. (2001). Cyclopentenone prostaglandins: New insights on biological activities and cellular targets. Med. Res. Rev., 21, 185-210.
23. Woodward, D.F., Spada, C.S., Hawley, S.B., Williams, L.S., Protzman, C.E. & Nieves, A.L. (1993). Further studies on ocular responses to DP receptor stimulation. Eur. J. Pharmacol., 230, 327-333.
24. Wright, D.H., Metters, K.M., Abramovitz, M. & Ford-Hutchinson, A.W. (1998). Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. Br. J. Pharmacol., 123, 1317-1324.
25. Wright, D.H., Nantel, F., Metters, K.M. & Ford-Hutchinson, A.W. (1999). A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. Eur. J. Pharmacol., 377, 101-115.
26. Zhu, X. & Birnbaumer, L. (1996). G protein subunits and the stimulation of phosphlipase C by Gs- and Gi-coupled receptors: Lack of receptor selectivity of Galpha(16) and evidence for a synergic interaction between Gbeta gamma and the alpha subunit of a receptor activated G protein. Proc. Natl. Acad. Sci. U.S.A., 93, 2827-2831.